These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37876959)

  • 1. Secondary penicillin prophylaxis for latent rheumatic heart disease: A naïve realism?
    Kothari SS
    Ann Pediatr Cardiol; 2023; 16(3):212-214. PubMed ID: 37876959
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.
    Beaton A; Okello E; Rwebembera J; Grobler A; Engelman D; Alepere J; Canales L; Carapetis J; DeWyer A; Lwabi P; Mirabel M; Mocumbi AO; Murali M; Nakitto M; Ndagire E; Nunes MCP; Omara IO; Sarnacki R; Scheel A; Wilson N; Zimmerman M; Zühlke L; Karthikeyan G; Sable CA; Steer AC
    N Engl J Med; 2022 Jan; 386(3):230-240. PubMed ID: 34767321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.
    Haran S; Crane N; Kazi S; Axford-Haines L; White A
    Aust J Rural Health; 2018 Apr; 26(2):119-125. PubMed ID: 29168587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.
    Wyber R; Boyd BJ; Colquhoun S; Currie BJ; Engel M; Kado J; Karthikeyan G; Sullivan M; Saxena A; Sheel M; Steer A; Mucumbitsi J; Zühlke L; Carapetis J
    Drug Deliv Transl Res; 2016 Oct; 6(5):572-8. PubMed ID: 27465618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary Prevention of Rheumatic Heart Disease in Nepal: Are We Going Backward?
    Regmi PR; Dhungel M; Kafle R
    JNMA J Nepal Med Assoc; 2022 Sep; 60(253):832-835. PubMed ID: 36705119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor long-term adherence to secondary penicillin prophylaxis in children with history of rheumatic fever.
    Amarilyo G; Chodick G; Zalcman J; Koren G; Levinsky Y; Somekh I; Harel L
    Semin Arthritis Rheum; 2019 Jun; 48(6):1019-1024. PubMed ID: 30415945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.
    Barr RK; Barber BW; Tait JR; Landersdorfer CB; Salman S; Musk GC; Page-Sharp M; Batty KT; Kado J; Manning L; Carapetis JR; Boyd BJ
    Eur J Pharm Biopharm; 2023 Aug; 189():240-250. PubMed ID: 37354997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.
    Kevat PM; Reeves BM; Ruben AR; Gunnarsson R
    Curr Cardiol Rev; 2017; 13(2):155-166. PubMed ID: 28093988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutics for rheumatic fever and rheumatic heart disease.
    Ralph AP; Currie BJ
    Aust Prescr; 2022 Aug; 45(4):104-112. PubMed ID: 36110174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of oral penicillin as secondary prophylaxis for rheumatic heart disease: a lesson from a low-prevalence rheumatic fever region.
    McGlacken-Byrne SM; Parry HM; Currie PF; Wilson NJ
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26531741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
    Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin Reactions in Patients With Severe Rheumatic Heart Disease: A Presidential Advisory From the American Heart Association.
    Sanyahumbi A; Ali S; Benjamin IJ; Karthikeyan G; Okello E; Sable CA; Taubert K; Wyber R; Zuhlke L; Carapetis JR; Beaton AZ;
    J Am Heart Assoc; 2022 Mar; 11(5):e024517. PubMed ID: 35049336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of Rheumatic Valvular Heart Disease in Patients Undergoing Prolonged Antibiotic Prophylaxis.
    Torres RPA; Torres RFA; de Crombrugghe G; Moraes da Silva SP; Cordeiro SLV; Bosi KA; Smeesters PR; Torres RSLA
    Front Cardiovasc Med; 2021; 8():676098. PubMed ID: 34250039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
    Gerber MA; Baltimore RS; Eaton CB; Gewitz M; Rowley AH; Shulman ST; Taubert KA
    Circulation; 2009 Mar; 119(11):1541-51. PubMed ID: 19246689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatic fever prophylaxis in South Africa--is bicillin 1,2 million units every 4 weeks appropriate?
    Daniels ED; Mohanlal D; Pettifor JM
    S Afr Med J; 1994 Aug; 84(8 Pt 1):477-81. PubMed ID: 7825080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association.
    Dajani A; Taubert K; Ferrieri P; Peter G; Shulman S
    Pediatrics; 1995 Oct; 96(4 Pt 1):758-64. PubMed ID: 7567345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis.
    Jaiteh LES; Drammeh L; Anderson ST; Mendy J; Ceesay S; D'Alessandro U; Carapetis J; Mirabel M; Erhart A
    BMC Cardiovasc Disord; 2021 Oct; 21(1):503. PubMed ID: 34663206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.